Dexcom Appoints Jon Coleman as Chief Commercial Officer
Go back to Dexcom Appoints Jon Coleman as Chief Commercial Officer| DexCom, Inc. (NASDAQ: DXCM) | Delayed: 70.14 +1.49 (2.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.65 | 52 Week High | $96.38 | |||
| Open | $68.43 | 52 Week Low | $47.92 | |||
| Day High | $70.38 | P/E | N/A | |||
| Day Low | $68.28 | EPS | $-0.42 | |||
| Volume | 6,872,578 | |||||
| Masimo Corporation (NASDAQ: MASI) | Delayed: 179.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $179.95 | 52 Week High | $62.00 | |||
| Open | $179.95 | 52 Week Low | $33.03 | |||
| Day High | $179.95 | P/E | 176.42 | |||
| Day Low | $179.95 | EPS | $1.02 | |||
| Volume | 7 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 24.29 +0.62 (2.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.67 | 52 Week High | $37.39 | |||
| Open | $23.74 | 52 Week Low | $28.25 | |||
| Day High | $24.35 | P/E | 14.72 | |||
| Day Low | $23.74 | EPS | $1.65 | |||
| Volume | 59,948,644 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 24.29 +0.62 (2.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.67 | 52 Week High | $37.39 | |||
| Open | $23.74 | 52 Week Low | $28.25 | |||
| Day High | $24.35 | P/E | 14.72 | |||
| Day Low | $23.74 | EPS | $1.65 | |||
| Volume | 59,948,644 | |||||

